7431 - 7440 of 8808 Results
Title
Year
-
RESTRICTEDTitle: MicroRNA profiling and the role of microRNA-132 in neurodegeneration using a rat modelJournal Name: Neuroscience LettersPublisher: Elsevier BVVol: 553Issue #:Start Page: 153End Page: 158Publication Date:Open Access(OA) Status: RESTRICTEDLicense:DOI - Digital Object Identifier: 10.1016/j.neulet.2013.08.001Citation Count: 60
-
RESTRICTEDTitle: Kinematic Adaptive Deep Brain Stimulation for Resting Tremor in Parkinson's DiseaseJournal Name: Movement DisordersPublisher: WileyVol: 31Issue #: 3Start Page: 426End Page: 428Publication Date:Open Access(OA) Status: RESTRICTEDLicense:DOI - Digital Object Identifier: 10.1002/mds.26482Citation Count: 129
-
OPENTitle: Autophagic stress activates distinct compensatory secretory pathways in neuronsJournal Name: Proceedings of the National Academy of SciencesPublisher: Proceedings of the National Academy of SciencesVol: 122Issue #: 28Start Page:End Page:Publication Date:Open Access(OA) Status: OPENLicense: cc-byDOI - Digital Object Identifier: 10.1073/pnas.2421886122Best OA location URL: https://www.pnas.org/doi/pdf/10.1073/pnas.2421886122Citation Count: 1
-
OPENTitle: Mitostasis in Neurons: Maintaining Mitochondria in an Extended Cellular ArchitectureJournal Name: NeuronPublisher: Elsevier BVVol: 96Issue #: 3Start Page: 651End Page: 666Publication Date:Open Access(OA) Status: OPENLicense:DOI - Digital Object Identifier: 10.1016/j.neuron.2017.09.055Best OA location URL: http://www.cell.com/article/S0896627317309248/pdfCitation Count: 503
- Oligomeric and phosphorylated alpha-synuclein as potential CSF biomarkers for Parkinson’s disease2016OPENTitle: Oligomeric and phosphorylated alpha-synuclein as potential CSF biomarkers for Parkinson’s diseaseJournal Name: Molecular NeurodegenerationPublisher: Springer Science and Business Media LLCVol: 11Issue #: 1Start Page:End Page:Publication Date:Open Access(OA) Status: OPENLicense: cc-byDOI - Digital Object Identifier: 10.1186/s13024-016-0072-9Best OA location URL: https://molecularneurodegeneration.biomedcentral.com/track/pdf/10.1186/s13024-016-0072-9Citation Count: 239
-
RESTRICTEDTitle: Clinical genetic testing in Parkinson’s disease should become part of routine patient careJournal Name: BrainPublisher: Oxford University Press (OUP)Vol: 147Issue #: 8Start Page: 2595End Page: 2597Publication Date:Open Access(OA) Status: RESTRICTEDLicense: other-oaDOI - Digital Object Identifier: 10.1093/brain/awae181Best OA location URL: https://academic.oup.com/brain/article-pdf/147/8/2595/58712344/awae181.pdfCitation Count: 4
-
OPENTitle: Biomarkers of neurodegeneration and glial activation validated in Alzheimer’s disease assessed in longitudinal cerebrospinal fluid samples of Parkinson’s diseaseJournal Name: PLOS ONEPublisher: Public Library of Science (PLoS)Vol: 16Issue #: 10Start Page: e0257372End Page: e0257372Publication Date:Open Access(OA) Status: OPENLicense: cc-by, cc-byDOI - Digital Object Identifier: 10.1371/journal.pone.0257372Best OA location URL: https://journals.plos.org/plosone/article/file?id=10.1371/journal.pone.0257372&type=printableCitation Count: 41
-
OPENTitle: LRRK2 Kinase Inhibition Rescues Deficits in Lysosome Function Due to Heterozygous GBA1 Expression in Human iPSC-Derived NeuronsJournal Name: Frontiers in NeurosciencePublisher: Frontiers Media SAVol: 14Issue #:Start Page:End Page:Publication Date:Open Access(OA) Status: OPENLicense: cc-byDOI - Digital Object Identifier: 10.3389/fnins.2020.00442Best OA location URL: https://www.frontiersin.org/articles/10.3389/fnins.2020.00442/pdfCitation Count: 44
-
OPENTitle: PP1 Phosphatase Complexes: Undruggable No LongerJournal Name: CellPublisher: Elsevier BVVol: 174Issue #: 5Start Page: 1049End Page: 1051Publication Date:Open Access(OA) Status: OPENLicense: publisher-specific-oa, elsevier-specific: oa user licenseDOI - Digital Object Identifier: 10.1016/j.cell.2018.08.007Best OA location URL: http://www.cell.com/article/S0092867418310237/pdfCitation Count: 11
-
RESTRICTEDTitle: Increased Brain Exposure of an Alpha-Synuclein Fibrillization Modulator by Utilization of an Activated Ester Prodrug StrategyJournal Name: ACS Chemical NeurosciencePublisher: American Chemical Society (ACS)Vol: 9Issue #: 11Start Page: 2542End Page: 2547Publication Date:Open Access(OA) Status: RESTRICTEDLicense:DOI - Digital Object Identifier: 10.1021/acschemneuro.8b00236Citation Count: 12